Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis
Abstract The mTOR inhibitor rapamycin ameliorates the clinical and biochemical phenotype of mouse, worm, and cellular models of mitochondrial disease, via an unclear mechanism. Here, we show that prolonged rapamycin treatment improved motor endurance, corrected morphological abnormalities of muscle,...
Saved in:
| Main Authors: | Gabriele Civiletto, Sukru Anil Dogan, Raffaele Cerutti, Gigliola Fagiolari, Maurizio Moggio, Costanza Lamperti, Cristiane Benincá, Carlo Viscomi, Massimo Zeviani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2018-10-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201708799 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the interactions of rapamycin with target receptors in A549 cancer cells: insights from molecular docking analysis
by: Sanjeev K. Ganesh, et al.
Published: (2025-01-01) -
Critical role of ROCK1 in AD pathogenesis via controlling lysosomal biogenesis and acidification
by: Chenghuan Song, et al.
Published: (2024-11-01) -
PTEN deficiency in postnatally developing Purkinje cells disrupts metabolic signaling, leading to dendritic abnormalities and sex-specific behavioral deficits
by: Lindsay J. Walsh, et al.
Published: (2025-07-01) -
Ezrin defines TSC complex activation at endosomal compartments through EGFR–AKT signaling
by: Giuliana Giamundo, et al.
Published: (2025-02-01) -
New insights into tuberous sclerosis complex: from structure to pathogenesis
by: Chao-Sheng Chen, et al.
Published: (2025-06-01)